Thyrocare Technologies Ltd - 539871 - Reg. 34 (1) Annual Report.
This is to inform you that the 23rd Annual General Meeting of the Company will be held at 10.30 a.m. at the Corporate Office of the Company situated at D-37/3, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400 073, to transact the ordinary and special business set out in the Notice of the meeting. Thyrocare Technologies Ltd - 539871 - Notice Of 23Rd Annual General Meeting ('AGM') And Annual Report 2022-23
Notice of 23rd Annual General Meeting("AGM") and Annual Report 2022-23 Thyrocare Technologies Ltd - 539871 - Intimation Under Regulation 30 And Regulation 30A In The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended From Time To Time ('Listing Regulations')
Intimation under Regulation 30 and Regulation 30 A in the SEBI (Listing and Disclosure Requirements) Regulations, 2015 Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Accepted the Resignation of Mr. Sachin Salvi which will take effect from July 31, 2023 Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company at their meeting held on July 14, 2023, inter-alia approved the appointment of Dr. Prapti Ishwar Gilada and Dr. Harshil Jiten Vora as an additional director designated as an Independent Director of the Company with effect from July 14, 2023. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investors/Analysts Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Meeting with Investors/Analysts
Manipal Group offers to inject Rs 1,000 cr in PharmEasy owner API Holdings: Report
It is important to note that API Holdings has to repay a debt of Rs 2,500 crore. Previously, the company had pledged the shares of its subsidiary Thyrocare to Goldman Sachs as collateral for this debt. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice to Equity shareholders regarding unclaimed Equity Shares due for transfer to IEPF. Thyrocare Technologies Ltd - 539871 - Closure of Trading Window
Intimation of trading window closure.